Your text here 1
DIABETIC CASE STUDY 1
Diabetic Case Study
Dove
Cruz
The University of Texas Arlington
College of Nursing and Health Innovation
In partial fulfillment of the
requirements of
N5334 Advanced Pharmacology
for APNs
Lynda Jarrell, DNP, APRN,
FNP-BC, CNE
6/25/2
0
This study source was downloaded by 100000839739811 from CourseHero.com on 04-02-2022 10:20:49 GMT -05:00
https://www.coursehero.com/file/70120587/N5334-CASE-STUDY-MARION-2docx/
, DIABETIC CASE STUDY 2
Assessment
1. DM Type
2. HTN
3. Hyperlipidemia
4. Obesity
Treatment Plan
Pharmacologic:
1. Aspirin 81 mg by mouth once daily (Arnett et al., 2019)
2. Metformin IR 500 mg by mouth once daily (Wexler, 2020)
3. Atorvastatin 40 mg by mouth once daily (Rosenson, 2020)
4. Lisinopril 5 mg by mouth once daily (Mann, 2020)
Provide rationale:
1. Aspirin 81 mg by mouth once daily; According to The American College of Cardiology,
“Low dose aspirin is considered to be primary prevention of cardiovascular disease
among select adults 40 to 70 years of age who are at higher risk of ASCVD risk but not at
risk for increased bleeding” (Arnett et al., 2019)
2. Metformin IR 500 mg by mouth once daily; According to Up to Date, “Metformin is the
initial medication of choice for hyperglycemia in type 2 diabetes along with lifestyle
interventions at the time of diagnosis” (Wexler, 2020)
3. Atorvastatin 40 mg by mouth once daily; According to Up to Date, “Statins such as
atorvastatins are the most powerful drugs for lowering low-density lipoprotein
cholesterol, with a reducing in the range of 30-63 percent” (Rosenson, 2020)
4. Lisinopril 5 mg by mouth once daily; According to Up to Date, “ACE inhibitors are the
first line of drugs in patients with diabetes or systolic dysfunction and in patients with
proteinuric chronic kidney disease” (Mann, 2020)
5. Heart healthy diet; According to Garber in the American Association of Clinical
Endocrinologists, “Lifestyle therapy begins with nutrition which contains of heart healthy
foods, low sodium, low fat, and reduced content of fat in diabetic and heart patients”
(Garber, et al., 2019)
6. Exercise: According to Garber in the American Association of Clinical Endocrinologists,
“Regular physical activity- both aerobic exercise and strength training- improves glucose
control, lipid levels, and BP” (Garber, et al., 2019)
7. Record blood pressures; “Self monitoring and keeping a blood pressure diary at home
may be associated with a modest reduction in systolic and diastolic blood pressure and
possibly increased likelihood of achieving target blood pressure” (Dynamed, 2020)
8. No alcohol or smoking; According to Garber in the American Association of Clinical
Endocrinologists “Smoking and alcohol cessation is an important component of lifestyle
therapy and involves avoidance of all tobacco products and alcohol is important in
reducing heart disease” (Garber et al., 2019)
Non Pharmacologic:
This study source was downloaded by 100000839739811 from CourseHero.com on 04-02-2022 10:20:49 GMT -05:00
https://www.coursehero.com/file/70120587/N5334-CASE-STUDY-MARION-2docx/
DIABETIC CASE STUDY 1
Diabetic Case Study
Dove
Cruz
The University of Texas Arlington
College of Nursing and Health Innovation
In partial fulfillment of the
requirements of
N5334 Advanced Pharmacology
for APNs
Lynda Jarrell, DNP, APRN,
FNP-BC, CNE
6/25/2
0
This study source was downloaded by 100000839739811 from CourseHero.com on 04-02-2022 10:20:49 GMT -05:00
https://www.coursehero.com/file/70120587/N5334-CASE-STUDY-MARION-2docx/
, DIABETIC CASE STUDY 2
Assessment
1. DM Type
2. HTN
3. Hyperlipidemia
4. Obesity
Treatment Plan
Pharmacologic:
1. Aspirin 81 mg by mouth once daily (Arnett et al., 2019)
2. Metformin IR 500 mg by mouth once daily (Wexler, 2020)
3. Atorvastatin 40 mg by mouth once daily (Rosenson, 2020)
4. Lisinopril 5 mg by mouth once daily (Mann, 2020)
Provide rationale:
1. Aspirin 81 mg by mouth once daily; According to The American College of Cardiology,
“Low dose aspirin is considered to be primary prevention of cardiovascular disease
among select adults 40 to 70 years of age who are at higher risk of ASCVD risk but not at
risk for increased bleeding” (Arnett et al., 2019)
2. Metformin IR 500 mg by mouth once daily; According to Up to Date, “Metformin is the
initial medication of choice for hyperglycemia in type 2 diabetes along with lifestyle
interventions at the time of diagnosis” (Wexler, 2020)
3. Atorvastatin 40 mg by mouth once daily; According to Up to Date, “Statins such as
atorvastatins are the most powerful drugs for lowering low-density lipoprotein
cholesterol, with a reducing in the range of 30-63 percent” (Rosenson, 2020)
4. Lisinopril 5 mg by mouth once daily; According to Up to Date, “ACE inhibitors are the
first line of drugs in patients with diabetes or systolic dysfunction and in patients with
proteinuric chronic kidney disease” (Mann, 2020)
5. Heart healthy diet; According to Garber in the American Association of Clinical
Endocrinologists, “Lifestyle therapy begins with nutrition which contains of heart healthy
foods, low sodium, low fat, and reduced content of fat in diabetic and heart patients”
(Garber, et al., 2019)
6. Exercise: According to Garber in the American Association of Clinical Endocrinologists,
“Regular physical activity- both aerobic exercise and strength training- improves glucose
control, lipid levels, and BP” (Garber, et al., 2019)
7. Record blood pressures; “Self monitoring and keeping a blood pressure diary at home
may be associated with a modest reduction in systolic and diastolic blood pressure and
possibly increased likelihood of achieving target blood pressure” (Dynamed, 2020)
8. No alcohol or smoking; According to Garber in the American Association of Clinical
Endocrinologists “Smoking and alcohol cessation is an important component of lifestyle
therapy and involves avoidance of all tobacco products and alcohol is important in
reducing heart disease” (Garber et al., 2019)
Non Pharmacologic:
This study source was downloaded by 100000839739811 from CourseHero.com on 04-02-2022 10:20:49 GMT -05:00
https://www.coursehero.com/file/70120587/N5334-CASE-STUDY-MARION-2docx/
